FDA Accepts GSK's BLA for 5-in-1 Meningococcal Vaccine
The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
Looking to the Future of Independent Pharmacy
Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.
FDA: Fasenra Approved As Add-On Maintenance Therapy for Severe Pediatric Asthma
Fasenra was initially approved in 2017 as an add on maintenance therapy in patients aged 12 years and older.
Podcast: Pharmacy Financing With First Financial Bank
Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.
FDA Approves Iloperidone for Acute Treatment of Manic, Mixed Episodes in Bipolar I
The drug was previously approved in 2009 to treat schizophrenia.
FDA Clears First Digital Therapeutic to Treat Major Depressive Disorder
Rejoyn from Otsuka Pharmaceutical and Click Therapeutics is a 6-week program that helps enhance cognitive control of emotions through brief therapy lessons and training exercises.
